Gvhd Highlights: Use Of Biomarkers To Guide Treatment

GvHD highlights: use of biomarkers to guide treatment

VJHemOnc – Video Journal of Hematology & HemOnc

The microbiota as a biomarker for GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

How I treat GVHD: Dr. James Ferrara explains how biomarkers can predict outcomes

MDedge: news and insights for busy physicians

Biomarker testing may transform treatment of acute GVHD (Part 1)

MDedge: news and insights for busy physicians

What is the latest update on biomarkers for assessing GvHD?

Amphiregulin as a monitoring biomarker during treatment of acute GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Biomarkers for Graft-Versus-Host Disease: Biomarkers and Alternatives to Corticosteroid Treatment

Managed Healthcare Executive

Biomarkers for Graft-Versus-Host Disease: Biomarkers as Companion Diagnostics

Managed Healthcare Executive

Biomarker testing may transform treatment of acute GVHD (Part 2)

MDedge: news and insights for busy physicians

Case 1: Personal Approach to Treatment for Acute GVHD

Targeted Oncology

Biomarkers for Graft-Versus-Host Disease: What Is a Biomarker?

Managed Healthcare Executive

Precision BMT Through Biomarkers

Icahn School of Medicine

Mapping the future of Hemopoietic Cell Transplants: MAGIC Biomarkers

Icahn School of Medicine

Biomarkers for Graft-Versus-Host Disease: The 5 Subtypes of Biomarkers

Managed Healthcare Executive

ST2 and REG3α as predictive biomarkers for GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

GvHD biomarker discovery and validation

VJHemOnc – Video Journal of Hematology & HemOnc

Advances and unmet needs in chronic GvHD

VJHemOnc – Video Journal of Hematology & HemOnc

Acute GVHD: Biomarkers and Biology

Vedolizumab for GI acute GvHD prophylaxis after allogeneic transplantation

VJHemOnc – Video Journal of Hematology & HemOnc

Overcoming the Challenges of Acute and Chronic GVHD

PeerView Oncology